Independent directory Public ClinicalTrials.gov records United States
Clinical Trials Finder
Objective public record navigation
ClinicalTrials.gov record
Recruiting Phase 3 Interventional

Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-3)

ClinicalTrials.gov ID: NCT07717892

Public ClinicalTrials.gov record NCT07717892. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search
ClinicalTrials.gov public records Last synced Oct 16, 2026, 5:04 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, 6-Week, Double-blind, Placebo- Controlled Trial of Solriamfetol in Adolescents Aged 12 to <18 Years With Attention Deficit Hyperactivity Disorder (ADHD)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study is a Phase 3, multi-center, randomized, 6-week, double-blind, placebo-controlled, parallel-group trial to assess the efficacy and safety of solriamfetol in adolescents aged 12 to \<18 years with ADHD.

Study identification

NCT ID
NCT07717892
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Axsome Therapeutics, Inc.
Industry
Enrollment
468 participants

Conditions and interventions

Conditions

Eligibility (public fields only)

Age range
12 Years to 17 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 25, 2026 (Actual)
Primary completion
Jun 30, 2028 (Estimated)
Completion
Jun 30, 2028 (Estimated)
Last update posted
Oct 13, 2026

2026 – 2028

United States locations

U.S. sites
28
U.S. states
16
U.S. cities
28
Facility City State ZIP Site status
Clinical Research Site Dothan Alabama 36303 Recruiting
Clinical Research Site Little Rock Arkansas 72211 Recruiting
Clinical Research Site Anaheim California 92805 Recruiting
Clinical Research Site Irvine California 92604 Recruiting
Clinical Research Site Long Beach California 90806 Recruiting
Clinical Research Site Los Angeles California 90015 Recruiting
Clinical Research Site Walnut Creek California 94596 Recruiting
Clinical Research Site Coral Gables Florida 33146 Recruiting
Clinical Research Site Gainesville Florida 32607 Recruiting
Clinical Research Site Jacksonville Florida 32256 Recruiting
Clinical Research Site Maitland Florida 32751 Recruiting
Clinical Research Site Orlando Florida 32801 Recruiting
Clinical Research Site Atlanta Georgia 30318 Recruiting
Clinical Research Site Bardstown Kentucky 40004 Recruiting
Clinical Research Site Owensboro Kentucky 42301 Recruiting
Clinical Research Site Springfield Massachusetts 01103 Recruiting
Clinical Research Site Worcester Massachusetts 01608 Recruiting
Clinical Research Site Jackson Mississippi 39206 Recruiting
Clinical Research Site Las Vegas Nevada 89128 Recruiting
Clinical Research Site Staten Island New York 10314 Recruiting
Clinical Research Site North Charleston South Carolina 29405 Recruiting
Clinical Research Site Memphis Tennessee 38119 Recruiting
Clinical Research Site Austin Texas 78759 Recruiting
Clinical Research Site Friendswood Texas 77546 Recruiting
Clinical Research Site San Antonio Texas 78229 Recruiting
Clinical Research Site Provo Utah 84604 Recruiting
Clinical Research Site Petersburg Virginia 23805 Recruiting
Clinical Research Site Everett Washington 98201 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07717892, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 13, 2026 · Synced Oct 16, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT07717892 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →